In keeping with family tradition, my niece has entered the radiology business. She is getting ready for her first RSNA meeting, and one day she asked me, “As a potential customer, what would you want to see or hear at our booth this year?” Her question, simple as it seemed, was hard to answer.
In keeping with family tradition, my niece has entered the radiology business. She is getting ready for her first RSNA meeting, and one day she asked me, "As a potential customer, what would you want to see or hear at our booth this year?" Her question, simple as it seemed, was hard to answer.
Outpatient centers, which in the past would have bought the latest and greatest, are fighting to keep their heads above water. They are closing or consolidating unprofitable centers, cutting budgets, looking for improved billing techniques, refinancing debt, shuffling equipment from one site to another, and freezing staff. This siege mentality has begun to spill into hospitals, where administrators now fear reimbursement cuts in the future. It all portends a lot of tire kickers, window shoppers, and dreamers at vendors' booths this year.
So given this climate, here is some advice I would offer my niece and her fellow RSNA exhibitors:
Vendors who understand their customers and the struggles they are facing will have a much better chance at making a sale as well as building a long-term relationship. This will reap many benefits in the years ahead as we learn to live with the DRA.
Steven R. Renard is a diagnostic imaging and radiology industry consultant with nearly 15 years of related experience, primarily in imaging center operations.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.